| QSAR-based virtual screening: advances and applications in drug discovery BJ Neves, RC Braga, CC Melo-Filho, JT Moreira-Filho, EN Muratov, ... Frontiers in pharmacology 9, 1275, 2018 | 408 | 2018 |
| Chalcone derivatives: promising starting points for drug design MN Gomes, EN Muratov, M Pereira, JC Peixoto, LP Rosseto, PVL Cravo, ... Molecules 22 (8), 1210, 2017 | 368 | 2017 |
| In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery LR de Souza Neto, JT Moreira-Filho, BJ Neves, RLBR Maidana, ... Frontiers in chemistry 8, 93, 2020 | 176 | 2020 |
| Pred‐hERG: A novel web‐accessible computational tool for predicting cardiac toxicity RC Braga, VM Alves, MFB Silva, E Muratov, D Fourches, LM Lião, ... Molecular informatics 34 (10), 698-701, 2015 | 176 | 2015 |
| A critical overview of computational approaches employed for COVID-19 drug discovery EN Muratov, R Amaro, CH Andrade, N Brown, S Ekins, D Fourches, ... Chemical Society Reviews 50 (16), 9121-9151, 2021 | 160 | 2021 |
| CoMPARA: collaborative modeling project for androgen receptor activity K Mansouri, N Kleinstreuer, AM Abdelaziz, D Alberga, VM Alves, ... Environmental Health Perspectives 128 (2), 027002, 2020 | 141 | 2020 |
| 4D-QSAR: perspectives in drug design CH Andrade, KFM Pasqualoto, EI Ferreira, AJ Hopfinger Molecules 15 (5), 3281-3294, 2010 | 141 | 2010 |
| Assessing the performance of 3D pharmacophore models in virtual screening: how good are they? RC Braga, CH Andrade Current topics in medicinal chemistry 13 (9), 1127-1138, 2013 | 137 | 2013 |
| Alarms about structural alerts VM Alves, EN Muratov, SJ Capuzzi, R Politi, Y Low, RC Braga, ... Green Chemistry 18 (16), 4348-4360, 2016 | 134 | 2016 |
| Tuning HERG out: antitarget QSAR models for drug development R C Braga, V M Alves, M FB Silva, E Muratov, D Fourches, A Tropsha, ... Current topics in medicinal chemistry 14 (11), 1399-1415, 2014 | 116 | 2014 |
| QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity MN Gomes, RC Braga, EM Grzelak, BJ Neves, E Muratov, R Ma, LL Klein, ... European journal of medicinal chemistry 137, 126-138, 2017 | 115 | 2017 |
| Déjà vu: stimulating open drug discovery for SARS-CoV-2 S Ekins, M Mottin, PRPS Ramos, BKP Sousa, BJ Neves, DH Foil, KM Zorn, ... Drug discovery today 25 (5), 928-941, 2020 | 110 | 2020 |
| Natural products as leads in schistosome drug discovery BJ Neves, CH Andrade, PVL Cravo Molecules 20 (2), 1872-1903, 2015 | 97 | 2015 |
| CATMoS: collaborative acute toxicity modeling suite K Mansouri, AL Karmaus, J Fitzpatrick, G Patlewicz, P Pradeep, D Alberga, ... Environmental health perspectives 129 (4), 047013, 2021 | 91 | 2021 |
| Predicting chemically-induced skin reactions. Part I: QSAR models of skin sensitization and their application to identify potentially hazardous compounds VM Alves, E Muratov, D Fourches, J Strickland, N Kleinstreuer, ... Toxicology and applied pharmacology 284 (2), 262-272, 2015 | 89 | 2015 |
| Pred-skin: a fast and reliable web application to assess skin sensitization effect of chemicals RC Braga, VM Alves, EN Muratov, J Strickland, N Kleinstreuer, ... Journal of chemical information and modeling 57 (5), 1013-1017, 2017 | 81 | 2017 |
| Discovery of new anti-schistosomal hits by integration of QSAR-based virtual screening and high content screening BJ Neves, RF Dantas, MR Senger, CC Melo-Filho, WCG Valente, ... Journal of medicinal chemistry 59 (15), 7075-7088, 2016 | 77 | 2016 |
| Predicting chemically-induced skin reactions. Part II: QSAR models of skin permeability and the relationships between skin permeability and skin sensitization VM Alves, E Muratov, D Fourches, J Strickland, N Kleinstreuer, ... Toxicology and applied pharmacology 284 (2), 273-280, 2015 | 75 | 2015 |
| 3D-QSAR approaches in drug design: perspectives to generate reliable CoMFA models. CC Melo-Filho, RC Braga, CH Andrade Current computer-aided drug design 10 (2), 148-159, 2014 | 74 | 2014 |
| Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms AC Puhl, EJ Fritch, TR Lane, LV Tse, BL Yount, CQ Sacramento, ... ACS omega 6 (11), 7454-7468, 2021 | 72 | 2021 |
Eugene MuratovUniversity of North Carolina在 email.unc.edu 的电子邮件经过验证
